Add BrightSurf on Google Email

WashU Medicine


Eye's motion detection sensors identified

A team of researchers has identified a specific neural circuit in the eye's retina that enables motion detection. This discovery could lead to the development of artificial retinas for people with vision loss. The study focused on mice, but similar cells are also found in other species, including humans.

Scientists find way to disrupt brain tumor stem cells

Researchers at Washington University School of Medicine identified a key player in maintaining brain tumor stem cells' ability to survive and replenish themselves. Disrupting this process using protein CDC20 has been shown to reduce tumor growth by up to 95 percent in mice, offering new hope for treating glioblastoma.

SourceWashU Medicine·JournalCell Reports·DateJun 11, 2015

Nanotherapy effective in mice with multiple myeloma

Researchers have designed a nanoparticle-based therapy that effectively treats mice with multiple myeloma, a cancer of immune cells in the bone marrow. The nanoparticles carry a Myc inhibitor, which blocks a protein active in many types of cancer, and increase survival by 23 days compared to control groups.

SourceWashU Medicine·JournalMolecular Cancer Therapeutics·DateMay 20, 2015

Diabetes drug may reduce heart attack risk in HIV patients

A new study suggests a diabetes drug may prevent cardiovascular problems in HIV-positive adults by reducing inflammation linked to heart disease and stroke. The drug, sitagliptin, improved metabolism and reduced inflammation in HIV patients taking antiretroviral therapy.

SourceWashU Medicine·JournalThe Journal of Clinical Endocrinology & Metabolism·DateMay 14, 2015

Fat signals control energy levels in the brain

The study found that a key enzyme produced by fat tissue regulates brain function and energy levels, suggesting an optimal amount of body fat for maximizing health and longevity. Mice with low NAMPT in fat tissue had impaired energy levels and physical activity, while those with high NAMPT exhibited increased physical activity.

SourceWashU Medicine·JournalCell Metabolism·DateApr 23, 2015

Study suggests ways to simplify health insurance enrollment

A new study suggests that using plain language, graphics, and stories can simplify the health insurance enrollment process for people who have never had insurance before. The research found that these methods helped participants make informed choices about their coverage options and increased their confidence in their decisions.

SourceWashU Medicine·JournalMedical Decision Making·DateApr 6, 2015

Kidney cancer detected early with urine test

Researchers developed a non-invasive method to screen for kidney cancer by measuring protein biomarkers in urine, achieving over 95% accuracy. The findings suggest the potential for an easy-to-use screening test, similar to mammograms or colonoscopies, to identify patients with kidney cancer at early stages.

SourceWashU Medicine·JournalJAMA Oncology·DateMar 19, 2015

Study sheds new light on asthma, COPD

A new study from Washington University School of Medicine has linked a protein called CLCA1 to the overproduction of mucus in diseases like asthma and COPD. Increased expression of CLCA1 increases the number of TMEM16A channels present in nearby cells, leading to more Ca2+ dependent chloride currents.

Stem cells lurking in tumors can resist treatment

Researchers have discovered that slow-growing brain cancer stem cells are resistant to treatment and can survive stress by producing a protein called Abcg1. The study suggests that using different drugs and higher dosages may be necessary to target these treatment-resistant stem cells.

SourceWashU Medicine·JournalCell Reports·DateMar 12, 2015

Harder-to-abuse OxyContin doesn't stop illicit use

A study by Washington University School of Medicine found that the abuse-deterrent formulation of OxyContin successfully reduced its illicit use, but only temporarily. As a result, many abusers switched to heroin due to cost-effectiveness and increased availability, highlighting the need for addressing the demand side of drug abuse.

SourceWashU Medicine·JournalJAMA Psychiatry·DateMar 11, 2015

Innovative light therapy reaches deep tumors

Researchers have developed a new light therapy that can reach deep tumors using nanoparticles and FDG, producing different kinds of free radicals that overwhelm tumor cells. This treatment shows promise in reducing cancer growth and increasing survival rates with minimal toxic side effects.

SourceWashU Medicine·JournalNature Nanotechnology·DateMar 9, 2015

Mental health soon after war-zone concussions predicts disability

Researchers found that early post-traumatic stress symptoms are the strongest predictors of later disability in military personnel with mild brain injuries. A study evaluated 38 patients with mild blast-related brain injury and 34 controls, showing that mental health assessments soon after injury were more predictive of long-term disab...

SourceWashU Medicine·JournalBrain·DateMar 4, 2015

Study shows who benefits most from statins

Research suggests statin therapy provides greatest benefit to patients with highest genetic risk of heart attack. Genetic analysis assesses heart attack risk independently of traditional factors, identifying those at higher baseline risk who reap greater benefits from therapy. The study's findings have implications for precision medici...

SourceWashU Medicine·JournalThe Lancet·DateMar 3, 2015

Investigational drug can reduce asthma flareups

A new investigational drug, reslizumab, has been shown to reduce asthma attacks in patients who have difficulty controlling the disorder with standard medications. The study found that patients treated with reslizumab were at least 50% less likely to experience severe asthma exacerbations.

SourceWashU Medicine·JournalThe Lancet Respiratory Medicine·DateFeb 23, 2015

Epigenome orchestrates embryonic development

Researchers at WashU Medicine found that the epigenome plays a significant part in guiding development in zebrafish embryos within the first 24 hours after fertilization. The study suggests an underappreciated fraction of the genome is involved in gene regulation, with many noncoding regions acting as developmental enhancers.

SourceWashU Medicine·JournalNature Communications·DateFeb 23, 2015

IUD, implant contraception effective beyond FDA-approved use

Researchers found hormonal IUDs and contraceptive implants to be highly effective one year beyond their approved duration of use, with no pregnancies reported in the implant group. The study aims to enroll a total of 800 women to determine if these methods are effective for up to three years beyond FDA-approved duration.

SourceWashU Medicine·JournalObstetrics and Gynecology·DateFeb 5, 2015

Pro-marijuana 'tweets' are sky-high on Twitter

Researchers analyzed over 7.6 million tweets about marijuana, finding that 77% were pro-pot, while only 5% were anti-marijuana. Pro-pot tweets often encouraged use and made claims about health benefits, reaching a large audience of young people at risk for substance abuse.

SourceWashU Medicine·JournalJournal of Adolescent Health·DateJan 22, 2015

New genetic clues found in fragile X syndrome

Researchers have discovered a unique case of fragile X syndrome with only two classic symptoms, allowing them to identify a previously unknown function of the gene. The study suggests that drugs recently tested as treatments for fragile X may be ineffective due to overactive transmitters.

SourceWashU Medicine·JournalProceedings of the National Academy of Sciences·DateJan 16, 2015

Laughing gas studied as depression treatment

A pilot study found that two-thirds of patients with treatment-resistant clinical depression experienced an improvement in symptoms after receiving nitrous oxide, compared to one-third who improved with a placebo. The researchers are encouraged by the results and plan to replicate the study and test various concentrations of laughing gas.

SourceWashU Medicine·JournalBiological Psychiatry·DateDec 9, 2014